OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Halozyme Therapeutics/  US40637H1095  /

IEX
5/24/2024  9:59:58 PM Chg. - Volume Bid- Ask- High Low
43.84USD - 34,816
Turnover: 1.52 mill.		 -Bid Size: - -Ask Size: - 43.99 42.98
GlobeNewswire 5/6 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 2/14 Genmab Publishes 2023 Annual Report
GlobeNewswire 11/6/2023 Acumen Pharmaceuticals, Inc. and Halozyme Enter Global Collaboration and License Agreement to Develo...
GlobeNewswire 2/22/2022 Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
GlobeNewswire 2/16/2022 Genmab Publishes 2021 Annual Report
GlobeNewswire 12/16/2021 Arcutis Appoints Mas Matsuda as General Counsel and Corporate Secretary
GlobeNewswire 12/15/2021 Surface Oncology Appoints Denice Torres as Chair of the Board of Directors
GlobeNewswire 9/2/2021 Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Off...
GlobeNewswire 6/30/2021 TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Progra...
GlobeNewswire 5/26/2021 Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors
GlobeNewswire 5/12/2021 Medicenna Appoints Immuno-Oncology Expert Dr. Mann Muhsin as Chief Medical Officer
GlobeNewswire 3/15/2021 Iovance Biotherapeutics Appoints Igor Bilinsky as Chief Operating Officer
GlobeNewswire 3/1/2021 Cerecor Appoints Schond L. Greenway as Chief Financial Officer
GlobeNewswire 9/22/2020 Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
GlobeNewswire 3/5/2020 Passage Bio Appoints Athena Countouriotis to Board of Directors
GlobeNewswire 11/12/2019 Bernadette Connaughton Appointed to Syneos Health Board of Directors
GlobeNewswire 7/2/2019 Madrigal Pharmaceuticals Announces Appointment of Jim Daly to Board of Directors
GlobeNewswire 6/11/2019 Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors
GlobeNewswire 2/28/2019 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
GlobeNewswire 2/15/2019 Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Car...
GlobeNewswire 2/4/2019 argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology
GlobeNewswire 12/27/2018 Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor ...
GlobeNewswire 12/11/2018 Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments
GlobeNewswire 12/4/2018 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therape...
GlobeNewswire 12/3/2018 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therap...